Otitis media therapy and drug resistance part 1: Management principles

Infections in Medicine

Volumn 18, Issue 4, 2001, Pages 212-216

  Leibovitz, Eugene ^a   Dagan, Ron ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Acute; Antibiotic resistance; Haemophilus influenzae; Otitis media; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; BIAXAN; CEFACLOR; CEFIXIME; CEFOTAXIME; CEFPODOXIME; CEFPODOXIME PROXETIL; CEFPROZIL; CEFTIBUTEN; CEFTRIAXONE; CEFUROXIME AXETIL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; CLIOCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LORACARBEF; MACROLIDE; OFLOXACIN; PENICILLIN G;

AGE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; COST BENEFIT ANALYSIS; DRUG BIOAVAILABILITY; DRUG CHOICE; DRUG HALF LIFE; DRUG METABOLISM; DRUG SAFETY; DRUG SCREENING; DRUG SENSITIVITY; DRUG USE; HUMAN; IC 50; INJECTION SITE; OTITIS MEDIA; REVIEW; STREPTOCOCCUS PNEUMONIAE; TREATMENT PLANNING; UNITED STATES;

EID: 0035041222     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Faden H, Duffy L, Boeve M. Otitis media: back to basics. Pediatr Infect Dis J. 1998;17:1105-1113.
2. Paradise JL, Rockette HE, Colborn DK, et al. Otitis media in 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life. Pediatrics. 1997;99:318-333.
3. Lanphear BP, Byrd RS, Auinger P, Hall CB. Increasing prevalence of recurrent acute otitis media among children in the United States. Pediatrics. 1997;99:E1.
4. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA. 1995;273:214-219.
5. Capra AM, Lieu TA, Black SB, et al. Costs of otitis media in a managed care population. Pediatr Infect Dis J. 2000;19:354-355.
6. Giebink GS. The microbiology of otitis media. Pcdiatr Infect Dis J. 1989;8(suppl):S18-S20.
7. Bluestone CD, Stephenson JS, Martin LM. Ten-year review of otitis media pathogens. Pediatr Infect Dis J. 1992;11(suppl)S7-S11.
8. Klein JO. Clinical implications of antibiotic resistance for the management of acute otitis media. Pediatr Infect Dis J. 1998;17:1084-1089.
9. Dagan R. Clinical significance of resistant organisms in otitis media. Pediatr Infect Dis J. 2000;19:378-382.
10. Kaleida PH, Casselbrandt ML, Rockette HE, et al. Amoxicillin or myringotomy or both for acute otitis media: results of a randomized clinical trial. Pediatrics. 1991;87:466-474.
11. Rosenfeld RM, Vertrees JE, Carr J, et al. Clinical efficacy of antimicrobial drugs for acute otitis media: metaanalysis of 5400 children from thirty-three randomized trials. J Pediatr. 1994;124:355-367.
12. Klein JO. Microbiologic efficacy of antibacterial drugs for acute otitis media. Pediatr Infect Dis J. 1993;12:973-975.
13. Del Beccaro MA, Mendelman PM, Inglis AF, et al. Bacteriology of acute otitis media: a new perspective. J Pediatr. 1992;120:81-84.
14. Rodriguez WJ, Schwartz RH. Streptococcus pneumoniae causes otitis media with higher fever and more redness of tympanic membranes than Haemophilus influenzae or Moraxella catarrhalis. Pediatr Infect Dis J. 1999;18:942-944.
15. Baquero F, Loza E. Antibiotic resistance of microorganisms involved in ear, nose and throat infections. Pediatr Infect Dis J. 1994;13(suppl 1): S9-S14.
16. Appelbaum PC. Epidemiology and in vitro susceptibility of drug-resistant Streptococcus pneumoniae. Pediatr Infect Dis J. 1996;15:932-934.
17. Jacobs MR. Increasing importance of antibiotic-resistant Streptococcus pneumoniae in acute otitis media. Pediatr Infect Dis J. 1996;15:940-943.
18. Jacobs MR, Dagan R, Appelbaum PC, Burch DJ. Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media. Antimicrob Agents Chemother. 1998;42:589-595.
19. Spangler SK, Jacobs MR, Appelbaum PC. In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUNY/SY5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cefdinir. Antimicrob Agents Chemother. 1994;38:2902-2904.
20. Spangler SK, Jacobs MR, Pankuch GA, Appelbaum PC. Susceptibility of 170 penicillin-susceptible and penicillin-resistant pneumococci to six oral cephalosporins, four quinolones, desacetylcefotaxime, Ro 23-9424 and RP 67829. J Antimicrob Chemother. 1993;31:273-280.
21. Venglarcik JS. Streptococcus pneumoniae antimicrobial susceptibility testing. Pediatr Infect Dis J. 2000;19:329-331.
22. Nelson CT, Mason EO, Kaplan SL. Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. Pediatr Infect Dis J. 1994;13:585-589.
23. Block SL, Harrison CJ, Hedrick JA, et al. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis J. 1995;14:751-759.
24. Goldbart A, Yagupsky P, Markus N, et al. Prevalence of antimicrobial resistance among pneumococcal isolates from children with otitis media in Southern Israel. Pediatr Infect Dis J. 1997;16:521-523.
25. Dagan R, Givon-Lavi N, Shkolnik L, et al. Acute otitis media caused by antibiotic-resistant Streptococcus pneumoniae in southern Israel: implication for immunizing with conjugate vaccines. J Infect Dis. 2000;181:1322-1329.
26. Leibovitz E, Raiz S, Piglansky L, et al. Resistance pattern of middle ear fluid isolates in acute otitis media recently treated with antibiotics. Pediatr Infect Dis J. 1998;17:463-469.
27. Leibovitz E, Dagan R, Piglansky L, et al. The bacteriologic and clinical efficacy of trimethoprim/sulfamethoxazole in the treatment of acute otitis media. In: Program and abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 26-29, 1999; San Francisco. Abstract 778.
28. Barnett ED, Klein JO. The problem of resistant bacteria for the management of acute otitis media. Pediatr Clin North Am. 1995;42:509-517.
29. Block SL. Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media. Pediatr Infect Dis J. 1997;16:449-456.
30. McCracken GH. Treatment of acute otitis media in an era of increasing microbial resistance. Pediatr Infect Dis J. 1998;17:576-579.
31. Marchant CD, Carlin SA, Johnson CE, Shurin PA. Measuring the comparative efficacy of antibacterial agents for acute otitis media: the "Pollyanna phenomenon." J Pediatr. 1992;120: 72-77.
32. Howie VM, Ploussard JH. The "in vivo sensitivity test" - bacteriology of middle ear exudate, during antimicrobial therapy in otitis media. Pediatrics. 1969;44:940-944.
33. Howie VM, Dillard R, Lawrence B. In vivo sensitivity test in otitis media: efficacy of antibiotics. Pediatrics. 1985;75:8-13.
34. Howie VM, Ploussard JH. Efficacy of fixed combination antibiotics versus separate components in otitis media. Clin Pediatr (Phila). 1972;11:205-214.
35. Howie VM. Eradication of bacterial pathogens from middle ear infections. Clin Infect Dis. 1992;14(suppl):S209-S210.
36. Blumer JL. Implications of pharmacokinetics in making choices for the management of acute otitis media. Pediatr Infect Dis J. 1998;17:565-570, 580.
37. Craig WA, Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J. 1996;15:255-259.
38. Craig WA. Pharmacokinetics/pharmacodynamics parameters; rationale for antibacterial dosing of mice and men. Clin Infect Dis. 1998; 26:1-12.
39. Craig WA. Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins. Diagn Microbiol Infect Dis. 1995; 22:89-96.
40. Dagan R, Leibovitz E, Jacobs M, et al. Bacteriologic response in acute otitis media caused by Haemophilus influenzae treated with azithromycin. In: Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 28-October 1, 1997; Toronto. Abstract K102.
41. Scaglione F. Predicting the clinical efficacy of antibiotics: toward definitive criteria. Pediatr Infect Dis J. 1997;16(suppl)S56-S59.
42. Dagan R, Leibovitz E, Fliss DM, et al. Bacteriologic efficacies of oral azithromycin and oral cefador in treatment of acute otitis media in infants and young children. Antimicrob Agents Chemother. 2000;44:43-50.
43. Dagan R, Abramson O, Leibovitz E, et al. Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin. Pediatr Infect Dis J. 1996;15:980-985.
44. Leibovitz E, Abramson O, Greenberg D, et al. Correlation between MIC values and bacteriologic outcome in pneumococcal acute otitis media. In: Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 16-19, 1996; New Orleans. Abstract LM59.
45. Dagan R, Abramson O, Leibovitz E, et al. Bacteriologic response to oral cephalosporins: are established susceptibility breakpoints appropriate in the case of acute otitis media? J Infect Dis. 1997;176:1253-1259.
46. Dagan R, Piglansky L, Yagupsky P, et al. Bacteriologic response to acute otitis media: comparison between azythromycin, cefaclor and amoxicillin. In: Program and abstracts of the 37th International Conference on Antimicrobial Agents and Chemotherapy; September 28-October 1, 1997; Toronto. Abstract K-103.
47. Dagan R. Can the choice of antibiotics for therapy of acute otitis media be logical? Eur J Clin Microbiol Infect Dis. 1998;17:1-5.
48. Leibovitz E, Piglansky L, Raiz S, et al. Bacteriologic efficacy of a three-day intramuscular ceftriaxone regimen in nonresponsive acute otitis media. Pediatr Infect Dis J. 1998;17:1126-1131.
49. Leibovitz E, Piglansky L, Raiz S, et al. Bacteriologic and clinical efficacy of one day vs. three day intramuscular ceftriaxone for treatment of nonresponsive acute otitis media in children. Pediatr Infect Dis J. 2000;19:1040-1045.
50. Dagan R, Johnson CE, McLinn S, et al. Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media. Pediatr Infect Dis J. 2000;19:95-104.
51. Jacobs MR. Increasing antibiotic resistance among otitis media pathogens and their susceptibility to oral agents based on pharmacodynamic parameters. Pediatr Infect Dis J. 2000; 19(suppl):S47-S56.
52. Gudnason T, Gudbrandsson F, Barsanti F, Kristinsson KG. Penetration of ceftriaxone into the middle ear fluid of children. Pediatr Infect Dis J. 1998;17:258-260.
53. Carlin SA, Marchant CD, Shurin PA, et al. Host factors and early therapeutic response in acute otitis media. J Pediatr. 1991;118:178-183.
54. Dagan R, Leibovitz E, Greenberg D, et al. Early eradication of pathogens from middle ear fluid during antibiotic treatment of acute otitis media is associated with improved clinical outcome. Pediatr Infect Dis J. 1998;17:776-782.
55. Harrison CJ, Marks MI, Welch DF. Microbiology of recently treated acute otitis media compared with previously untreated acute otitis media. Pediatr Infect Dis J. 1985;4:641-646.
56. Cohen R, de la Rocque F, Boucherat M, et al. Treatment failure in otitis media: an analysis. J Chemother. 1994;6(suppl 4):17-24.
57. Pichichero ME, Pichichero CL. Persistent acute otitis media: I. Causative pathogens. Pediatr Infect Dis J. 1995;14:178-183.
58. del Castillo F, Baquero-Artigao F, Garcia-Perea A. Influence of recent antibiotic therapy on antimicrobial resistance of Streptococcus pneumoniae in children with acute otitis media in Spain. Pediatr Infect Dis J. 1998;17:94-97.
59. Dowell SF, Butler JC, Giebink GS, et al. Acute otitis media: management and surveillance in an era of pneumococcal resistance - a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J. 1999;18:1-9.